Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, November 23, 2009

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: GOG

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.